C22.1
BillableIntrahepatic bile duct carcinoma
HCC Category Mapping
What This Code Means
A cancer that develops in the bile ducts inside the liver. This is a rare type of liver cancer distinct from hepatocellular carcinoma.
Coding Tips
- •Ensure documentation confirms intrahepatic location (inside liver) versus extrahepatic bile ducts
- •Note any associated conditions like primary sclerosing cholangitis or liver fluke infection
Clinical Significance
Intrahepatic cholangiocarcinoma (bile duct carcinoma within the liver) is the second most common primary liver malignancy and is increasing in incidence globally. It is a highly aggressive cancer with limited treatment options and a poor prognosis, with five-year survival rates typically below 10% for advanced disease. Accurate distinction from hepatocellular carcinoma and extrahepatic cholangiocarcinoma is critical because treatment approaches differ significantly.
Documentation Requirements
- ✓Pathological confirmation of intrahepatic cholangiocarcinoma (bile duct origin within the liver)
- ✓Distinction from hepatocellular carcinoma and mixed tumors
- ✓Stage of disease
- ✓Any associated conditions (primary sclerosing cholangitis, liver fluke infection, hepatolithiasis)
- ✓Molecular markers if tested (isocitrate dehydrogenase mutations, fibroblast growth factor receptor fusions)
Excludes 1 — Do NOT code together
- malignant neoplasm of hepatic duct (C24.0)